index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Activin Receptors Animal/physiopathology L-Type Genomic Metabolism DMD Duchenne DMD dystrophy Delivery Becker muscular dystrophy Molecular docking Modificateurs de gènes DHPR α1S Centronuclear myopathy Knockout Muscular dystrophy Muscle Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Immunoglobulin Fc Fragments/pharmacology Becker muscular dystrophy BMD Autophagy Cachexia Inbred mdx Mitochondrial fission Animals LncRNA LKB1 Gene Expression Regulation/drug effects Dystrophin-EGFP Gene expression Myogenesis Gene modifiers Génomique Diseases NNOS Dystrophie Musculaire de Becker BMD Invivo Hepatocellular carcinoma LncARN Hear Energy Metabolism/drug effects Calcium Channels Inhibitors Inbred C57BL Cell Biology Human Umbilical Vein Endothelial Cells BMD Dystrophy Cardiomyopathie Dynamin 2 CaVβs Dystrophin central domain Exon skipping Morphogenesis Cells Multi resolution modeling Muscle development Long noncoding RNA Cell Line NAD+ Allele‐specific silencing therapy Base Sequence Mice Mdx mouse CaV subunits Drp1 Muscular Dystrophy Ex-vivo Humans Calcium Muscles/physiopathology Liver CD38 Long QT CTNNB1 Muscle Strength MiARN Clinical trials Cardiomyopathy Homeostasis Duchenne muscular dystrophy Dystrophie Musculaire de Duchenne DMD Cultured MES Dystrophine Molecular Sequence Data Duchenne muscular dystrophy DMD Muscle Biology Dystrophin Myotendinous junction Becker BMD muscular dystrophy Antisense oligonucleotides Epigenetics Muscular Atrophy Skeletal muscle Male Cell homeostasis DMO Multiresolution modeling Dystrophie musculaire de Becker Multi exon skipping